MASCC 2025 Presidential Training Fellowship Spotlight: Dr. Wang Yanfei

OncoDaily highlights one of seven outstanding oncology leaders recognized with the MASCC Presidential Training Fellowship for their commitment to advancing supportive cancer care worldwide.

The Multinational Association of Supportive Care in Cancer (MASCC) Presidential Training Fellowship is one of the most prestigious honors for emerging leaders in oncology, recognizing early-career physicians and researchers who are redefining cancer care through innovation, education, and international collaboration. Each year, only a small group of exceptional individuals is chosen from around the globe to represent the future of supportive oncology.

As part of OncoDaily’s exclusive MASCC 2025 coverage, we are spotlighting this year’s seven fellowship recipients. Today, we feature Dr. Wang Yanfei, a leading oncologist from China whose work integrates cutting-edge research and clinical practice to transform supportive care delivery.

About Dr. Wang Yanfei

Dr. Wang Yanfei is an Associate Chief Physician and Medical Doctor at Peking University Cancer Hospital, where she also serves as Deputy Director of the Day Oncology Unit, the first MASCC-Designated Center of Excellence in Supportive Care in Cancer in China. Her research focuses on integrating supportive care into outpatient chemotherapy, optimizing cancer nutrition and metabolism, and improving the management of adverse effects of anti-cancer therapies.

Over the course of her career, Dr. Wang has led influential studies addressing cancer cachexia, malnutrition, cancer-associated venous thromboembolism, cancer-induced nausea and vomiting, digital therapies for advanced cancer patients, and the safety of immunotherapy in head and neck squamous cell carcinoma. She has also played a key role in shaping expert consensus guidelines, including the widely referenced Expert Consensus on Clinical Management of Cancer Therapy-Related Thrombocytopenia.

In addition to her clinical achievements, Dr. Wang is widely recognized as a passionate educator and mentor, actively training the next generation of oncology specialists. Her work emphasizes holistic care, multidisciplinary teamwork, and a forward-thinking approach to cancer treatment.

Her leadership extends beyond clinical research. Dr. Wang holds important positions within leading medical organizations such as the Chinese Society of Clinical Oncology (CSCO), the China Anti-Cancer Association (CACA), and the Chinese Society for Parenteral and Enteral Nutrition (CSPEN). Recognized by the Beijing Municipal Health Commission as a health science popularization expert, she has published extensively in peer-reviewed journals and continues to advocate for multidisciplinary, value-based approaches to cancer care.

Her contributions align closely with MASCC’s Supportive Care 2030 ambition statements, which outline practical goals for improving supportive oncology worldwide.

Dr. Wang Yanfei on Receiving the Fellowship

“It is an extraordinary honor to be awarded the MASCC Presidential Training Fellowship, and I am profoundly grateful to be one of only seven recipients selected worldwide. MASCC’s slogan – ‘Supportive care makes excellent cancer care possible’ – deeply resonates with me, as I have witnessed firsthand the life-changing impact of early, multidisciplinary interventions on patients and their families.

This fellowship reflects MASCC’s unwavering commitment to innovation, education, and global collaboration. I am eager to strengthen partnerships between MASCC and supportive care professionals in China, advancing the ambition of Supportive Care 2030 and ensuring that all cancer patients have access to the highest standards of care.

This opportunity is both a personal milestone and a profound responsibility. I look forward to learning from MASCC’s global community and contributing to a future where supportive care is fully integrated into cancer care worldwide.”

Stay tuned to OncoDaily’s MASCC 2025 coverage as we feature the remaining fellowship awardees, each bringing unique expertise and vision to the future of supportive oncology. These profiles aim to inspire global dialogue, encourage collaboration, and celebrate the professionals working tirelessly to elevate cancer care standards worldwide.

More posts featuring MASCC 2025.

Written by Sergey Badalyan, MD.